AbbVie (ABBV) Q4 earnings preview: Generic competition might weigh on results
With only a few weeks left for closing the high-value acquisition of Allergan, AbbVie (NYSE: ABBV) is busy doing the groundwork for the integration. The…
With only a few weeks left for closing the high-value acquisition of Allergan, AbbVie (NYSE: ABBV) is busy doing the groundwork for the integration. The…
— World Wresting Entertainment (NYSE: WWE) reported fourth quarter 2019 earnings of $0.78 per share vs. $0.73 expected. — Revenue rose 18% year-over-year to $322.8…
— Medical device maker Abiomed, Inc. (NASDAQ: ABMD) reported net income of $69.2 million or $1.51 per share for the third quarter of 2020, vs.…
— Kellogg (NYSE: K) reported its fourth-quarter 2019 adjusted earnings of $0.91 per share versus $0.85 per share expected. — Net sales decreased by 2.8%…
— Sanofi (NASDAQ: SNY) reported net loss of EUR 10 million or EUR 0.01 per share for the fourth quarter of 2019, on IFRS basis,…
— Tyson Foods, Inc. (NYSE: TSN) reported earnings of $1.66 per share in the fourth quarter of 2019, vs $1.65 per share expected. — Total sales rose…
In the final quarter of fiscal 2019, Philip Morris International (NYSE: PM) posted results that were slightly above the Wall Street expectations, nudging the stock…
— Cardinal Health (NYSE: CAH) reported second-quarter 2020 non-GAAP EPS attributable to the company of $1.52 vs. $1.22 expected. — Revenue increased 5% to $39.7…
— Yum! Brands Inc. (NYSE: YUM) reported Q4 2019 earnings of $1.00 per share, vs. $1.13 expected. — Revenues grew 9% to $1.7 billion, vs.…
Bristol-Myers Squibb Company (NYSE: BMY) slipped to a loss in the fourth quarter of 2019 from a profit last year, due to the amortization of…